Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-13

Clinical Trial Update: Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects [Phase 1]

View source ↗

Summary

GlaxoSmithKline completed a Phase 1 drug-drug interaction study evaluating eltrombopag with boceprevir and eltrombopag with telaprevir in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boceprevir (boceprevir)
  • Eltrombopag (eltrombopag)
  • Telaprevir (telaprevir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombocytopaenia | Phase 1 | Status: COMPLETED